DEBRA CHINNERY: Open Payments
NPI 1225127582 · HAMPTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$479 in 14 payments from 7 companies in 2025. Trend: 2023 $323 · 2024 $932 · 2025 $479
Food & beverage: $479
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $233 |
| Novo Nordisk Inc | 2 | $109 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $32 |
| Lilly USA, LLC | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
Products named: OTEZLA, REPATHA, Ozempic, Auvelity, REXULTI, MOUNJARO, AIRSUPRA, VIBERZI.
Industry payments across VA — which companies pay providers there.
